Researchers at Houston’s Baylor College of Medicine last week began Phase 2 clinical trials for a Zika vaccine that is expected to have results as early as the end of this year.
Andrew Pekosz, a professor of microbiology and immunology at Johns Hopkins University’s Bloomberg School of Public Health, praised the vaccine’s potential to prevent disease, as well as how quickly clinical trials have taken place.
“It’s really been a light-speed endeavor,” Pekosz, who was...